166742-96-7 Usage
Description
(R)-methyl 1-(methoxyamino)-1-oxo-3-phenylpropan-2-ylcarbamate is a synthetic compound characterized by its complex chemical structure. It is a carbamate derivative, which is a functional group often utilized in the fields of insecticides and pharmaceuticals. This specific compound features a carbamate group attached to a phenylpropan-2-yl unit, along with a methoxyamino and an oxo substituent. The (R)-methyl configuration denotes the stereochemistry at the chiral center of the molecule. Its potential applications may lie in the realm of medicinal chemistry or as a chemical intermediate in organic synthesis. However, further research is required to explore and confirm its properties and uses.
Uses
Used in Pharmaceutical Industry:
(R)-methyl 1-(methoxyamino)-1-oxo-3-phenylpropan-2-ylcarbamate is used as a potential candidate in medicinal chemistry due to its unique chemical structure and the presence of a carbamate group, which is commonly found in various pharmaceutical compounds. Its application reason is based on the possibility of it being a precursor to new drugs or having biological activity that can be harnessed for therapeutic purposes.
Used in Chemical Synthesis:
In the field of organic synthesis, (R)-methyl 1-(methoxyamino)-1-oxo-3-phenylpropan-2-ylcarbamate is used as a chemical intermediate. The application reason is its complex structure and functional groups, which may allow for further reactions and modifications to create a variety of other compounds with different properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 166742-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,7,4 and 2 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 166742-96:
(8*1)+(7*6)+(6*6)+(5*7)+(4*4)+(3*2)+(2*9)+(1*6)=167
167 % 10 = 7
So 166742-96-7 is a valid CAS Registry Number.
166742-96-7Relevant articles and documents
Sustained release tablet formulation to treat Parkinson's disease
-
, (2008/06/13)
The sustained release tablet of (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5-ij]-quinolin-2(1H)-one (Z)-2-butenedioate (1:1) which is disclosed permits twice daily administration of (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5-ij]-quinolin-2(1H)-one (
Heterocyclic amines having central nervous system activity
-
, (2008/06/13)
Tricyclic nitrogen containing compounds, having anxiolytic and anti-depressant activity and central nervous system activity of the following structural formula: STR1 and pharmaceutically acceptable salts thereof wherein R1 and R2 are
